1. Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression
   Sangmin Kim et al, 2016, Tumor Biology CrossRef
2. Interplay between Cell-Surface Receptors and Extracellular Matrix in Skin
   Svenja Kleiser et al, 2020, Biomolecules CrossRef
3. Tackling of Renal Carcinogenesis in Wistar Rats by Silybum marianum Total Extract, Silymarin, and Silibinin via Modulation of Oxidative Stress, Apoptosis, Nrf2, PPARγ, NF-κB, and PI3K/Akt Signaling Pathways
   Nour Y. S. Yassin et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
4. The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
   Marcin Kosmalski et al, 2022, Journal of Clinical Medicine CrossRef
5. Transcriptome profiling reveals Silibinin dose-dependent response network in non-small lung cancer cells
   Jagan Mohan Kaipa et al, 2020, PeerJ CrossRef
6. RNA‐binding protein‐regulated fibronectin is essential for EGFR‐activated metastasis of head and neck squamous cell carcinoma
   Jiunn‐Min Shieh et al, 2023, The FASEB Journal CrossRef
7. Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis
   Manoj Kumar et al, 2016, Tumor Biology CrossRef
8. Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways
   Mitsuho Imai-Sumida et al, 2017, Oncotarget CrossRef
9. Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
   Daeun You et al, 2017, BMB Reports CrossRef
10. Silibinin: a potential old drug for cancer therapy
    Xing-Xing Zhu et al, 2016, Expert Review of Clinical Pharmacology CrossRef
11. Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
    Jeonghun Han et al, 2019, Journal of Oncology CrossRef
12. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer
    Tahereh Hosseinabadi et al, 2019, Phytotherapy Research CrossRef
13. Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
    Jie Yuan et al, 2015, Scientific Reports CrossRef
14. Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases
    Shruti Mishra et al, 2019, Cellular and Molecular Life Sciences CrossRef
15. An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
    Hina Qayoom et al, 2021, Future Oncology CrossRef
16. Natural remedies and functional foods as angiogenesis modulators
    Mehmet Varol, 2020, Functional Foods in Cancer Prevention and Therapy CrossRef
17. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
    Hua Luo et al, 2019, Chinese Medicine CrossRef
18. Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
    Md. Abdul Aziz et al, 2021, Life Sciences CrossRef
19. Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma
    Ommoleila Molavi et al, 2015, Leukemia & Lymphoma CrossRef
20. The Anticancer Properties of Silibinin: Its Molecular Mechanism and Therapeutic Effect in Breast Cancer
    Agata Binienda et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
21. Delivery and Anti-Psoriatic Effect of Silibinin-Loaded Polymeric Micelles: An Experimental Study in the Psoriatic Skin Model
    Fateme Chavoshy et al, 2020, Current Drug Delivery CrossRef
22. Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy
    Joaquim Bosch-Barrera et al, 2015, Cancer Treatment Reviews CrossRef
23. STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
    Jiang-Jiang Qin et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef